ARTELO BIOSCIENCES INC (ARTL) Fundamental Analysis & Valuation

NASDAQ:ARTL • US04301G6070

Current stock price

3.19 USD
-1.66 (-34.23%)
At close:
3.45 USD
+0.26 (+8.15%)
After Hours:

This ARTL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ARTL Profitability Analysis

1.1 Basic Checks

  • ARTL had negative earnings in the past year.
  • In the past year ARTL has reported a negative cash flow from operations.
  • ARTL had negative earnings in each of the past 5 years.
  • In the past 5 years ARTL always reported negative operating cash flow.
ARTL Yearly Net Income VS EBIT VS OCF VS FCFARTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of ARTL (-459.80%) is worse than 93.26% of its industry peers.
Industry RankSector Rank
ROA -459.8%
ROE N/A
ROIC N/A
ROA(3y)-246.72%
ROA(5y)-169.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARTL Yearly ROA, ROE, ROICARTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ARTL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARTL Yearly Profit, Operating, Gross MarginsARTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. ARTL Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for ARTL has been increased compared to 1 year ago.
  • ARTL has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ARTL has a worse debt to assets ratio.
ARTL Yearly Shares OutstandingARTL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M
ARTL Yearly Total Debt VS Total AssetsARTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • ARTL has an Altman-Z score of -45.86. This is a bad value and indicates that ARTL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -45.86, ARTL is doing worse than 90.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -45.86
ROIC/WACCN/A
WACCN/A
ARTL Yearly LT Debt VS Equity VS FCFARTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

2.3 Liquidity

  • ARTL has a Current Ratio of 0.17. This is a bad value and indicates that ARTL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.17, ARTL is not doing good in the industry: 93.26% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.17 indicates that ARTL may have some problems paying its short term obligations.
  • ARTL's Quick ratio of 0.17 is on the low side compared to the rest of the industry. ARTL is outperformed by 92.23% of its industry peers.
Industry RankSector Rank
Current Ratio 0.17
Quick Ratio 0.17
ARTL Yearly Current Assets VS Current LiabilitesARTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ARTL Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 23.83% over the past year.
EPS 1Y (TTM)23.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, ARTL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.36% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y76%
EPS Next 2Y36.79%
EPS Next 3Y32.14%
EPS Next 5Y15.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARTL Yearly Revenue VS EstimatesARTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ARTL Yearly EPS VS EstimatesARTL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -20 -40 -60

More info and screens

Find the best growth stocksShow best growing peers

1

4. ARTL Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ARTL. In the last year negative earnings were reported.
  • Also next year ARTL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARTL Price Earnings VS Forward Price EarningsARTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARTL Per share dataARTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -10 -20 -30 -40

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ARTL's earnings are expected to grow with 32.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.79%
EPS Next 3Y32.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ARTL Dividend Analysis

5.1 Amount

  • No dividends for ARTL!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARTL Fundamentals: All Metrics, Ratios and Statistics

ARTELO BIOSCIENCES INC

NASDAQ:ARTL (3/26/2026, 8:04:53 PM)

After market: 3.45 +0.26 (+8.15%)

3.19

-1.66 (-34.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-24
Earnings (Next)05-11
Inst Owners4.64%
Inst Owner Change198.09%
Ins Owners2.77%
Ins Owner Change0%
Market Cap2.26M
Revenue(TTM)N/A
Net Income(TTM)-12.88M
Analysts43.33
Price TargetN/A
Short Float %N/A
Short Ratio0.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-138.58%
Min EPS beat(2)-374.65%
Max EPS beat(2)97.5%
EPS beat(4)1
Avg EPS beat(4)-187.85%
Min EPS beat(4)-442.99%
Max EPS beat(4)97.5%
EPS beat(8)4
Avg EPS beat(8)-105.93%
EPS beat(12)6
Avg EPS beat(12)-75.33%
EPS beat(16)8
Avg EPS beat(16)-56.99%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-200%
EPS NY rev (3m)-200%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-41.82
EYN/A
EPS(NY)-10.04
Fwd EYN/A
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-12
OCFYN/A
SpS0
BVpS-1.79
TBVpS-4.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -459.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-246.72%
ROA(5y)-169.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.17
Quick Ratio 0.17
Altman-Z -45.86
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.43%
EPS Next Y76%
EPS Next 2Y36.79%
EPS Next 3Y32.14%
EPS Next 5Y15.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.04%
OCF growth 3YN/A
OCF growth 5YN/A

ARTELO BIOSCIENCES INC / ARTL Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ARTELO BIOSCIENCES INC (ARTL) stock?

ChartMill assigns a fundamental rating of 0 / 10 to ARTL.


Can you provide the valuation status for ARTELO BIOSCIENCES INC?

ChartMill assigns a valuation rating of 1 / 10 to ARTELO BIOSCIENCES INC (ARTL). This can be considered as Overvalued.


How profitable is ARTELO BIOSCIENCES INC (ARTL) stock?

ARTELO BIOSCIENCES INC (ARTL) has a profitability rating of 0 / 10.


Can you provide the financial health for ARTL stock?

The financial health rating of ARTELO BIOSCIENCES INC (ARTL) is 0 / 10.


What is the expected EPS growth for ARTELO BIOSCIENCES INC (ARTL) stock?

The Earnings per Share (EPS) of ARTELO BIOSCIENCES INC (ARTL) is expected to grow by 76% in the next year.